Contraception 1605 - Contraceptive Technology Update - May 01, 2012

Target Audience:

This activity is intended for OB/GYNs, nurses, nurse practitioners, and other family planners.

Accreditation:

AHC Media is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

Credit Designation:

This activity has been approved for 1.25 nursing contact hours using a 60-minute contact hour.

Provider approved by the California Board of Registered Nursing, Provider # 14749, for 1.25 Contact Hours.

Nurses licensed in California should retain this credit letter for four years.

Faculty

Consulting Editor
Robert A. Hatcher, MD, MPH
Senior Author, Contraceptive Technology
Professor of Gynecology and Obstetrics
Emory University School of Medicine
Atlanta

Author
Rebecca Bowers

Executive Editor
Joy Dickinson
AHC Media

Nurse Reviewer
Sharon B. Schnare, RN, FNP, CNM, MSN, FAANP
Clinical Instructor
Department of Family and Child Nursing
University of Washington Seattle School of Nursing

Subjects:

  • Update: Women at high HIV risk can continue hormonal contraceptives
  • Alert is issued for mislabeled OCs
  • Progestin-only pill eyed as OTC OC candidate
  • Threat up for gonorrhea that is multi-drug resistant
  • New criteria clarify menopause stages
  • Case report: Use texts to reach young people
  • New HIV program launched by CDC

Objectives:

  • identify clinical, legal, or scientific issues related to development and provisions of contraceptive technology or other reproductive services
  • describe how those issues affect services and patient care
  • integrate practical solutions to problems and information into daily practices, according to advice from nationally recognized family planning experts
  • provide practical information that is evidence-based to help clinicians deliver contraceptives sensitively and effectively

Financial Disclosure:

Consulting Editor Robert A. Hatcher, MD, MPH, Author Rebecca Bowers, Executive Editor Joy Dickinson, report no consultant, stockholder, speaker's bureau, research, or other financial relationships with companies having ties to this field of study. Sharon Schnare (Nurse Reviewer) discloses that she is a retained consultant and a speaker for Barr Laboratories, Berlex, and Organon; she is a consultant for 3M Pharmaceuticals; and she is a speaker for FEI Women's Health, Ortho-McNeil Pharmaceuticals, and Wyeth-Ayerst Pharmaceuticals.

Copyright 2012 AHC Media. All rights reserved.